Overview

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline

Status:
Completed

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

Summary

To provide extended access to Ixabepilone therapy to subjects with metastatic breast cancer who have completed the previous Phase II study (CA163-107)

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb
R-Pharm

Treatments:

Epothilones